Meeting
2023 ASCO Annual Meeting
FAK inhibition with novel FAK/ALK inhibitor APG-2449 could overcome resistance in NSCLC patients who are resistant to second-generation ALK inhibitors.
Authors
Yuxiang Ma
Sun Yat-sen University Cancer Center, Guangzhou, China
Yuxiang Ma , Hongyun Zhao , Jianhua Chen , Zhengbo Song , Yanqiu Zhao , Yubiao Guo , Gang Wu , Wenwei Zhou , Xiaoqing Yu , Fangfang Gao , Ruiguang Zhang , Jian Fang , Xiaoyan Lin , Xiaohong Tian , Yanhua Tu , Juan Yu , GuangLin Liu , Yifan Zhai , Li Zhang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Clinical Trial Registration Number
NCT03917043
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 9015)
DOI
10.1200/JCO.2023.41.16_suppl.9015
Abstract #
9015
Poster Bd #
3
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Efficacy and safety of SY-3505, a third-generation ALK TKI, in ALK-positive advanced non-small cell lung cancer: Results from a phase I/II, multi-center study.
First Author: Yuankai Shi
Poster
2022 ASCO Annual Meeting
First-in-human phase I results of APG-2449, a novel FAK and third-generation ALK/ ROS1 tyrosine kinase inhibitor (TKI), in patients (pts) with second-generation TKI-resistant ALK/ROS1+ non–small cell lung cancer (NSCLC) or mesothelioma.
First Author: Hongyun Zhao
Poster
2024 ASCO Annual Meeting
Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in non-small-cell lung cancer (NSCLC) with c-MET exon 14 skipping mutations (METex14).
First Author: Mariana da Rocha Almeida Brandao
Poster
2022 ASCO Annual Meeting
Efficacy and safety of patritumab deruxtecan (HER3-DXd) in advanced/metastatic non-small cell lung cancer (NSCLC) without EGFR-activating mutations.
First Author: Conor Ernst Steuer